The results presented here also suggest that, in cancer cells, rational design of stable peptides, based on the Shepherdin model [49], or chemical drugs could be an approach to target Hsp27 oncogenic functions by counteracting its interaction with specific oncogenic client proteins. Here, HSPB1 is linked to cancer.